Sulforaphane Supplements Manufacturer

Broccoli Seed Extract vs. Broccoli Sprout Extract vs. Mature Broccoli Extract

KS Nutripharma Recommendation

For most commercial sulforaphane supplements, we recommend standardized broccoli seed extract or broccoli sprout extract containing 10–13% glucoraphanin, as these materials provide the best balance of active compound concentration, batch consistency, manufacturing stability, and commercial scalability.

Mature broccoli extract remains a valuable botanical ingredient for whole-food nutrition products, but it is generally not the preferred source for high-potency sulforaphane supplements due to its naturally low glucoraphanin content.

Standardized Glucoraphanin

Glucoraphanin is the most widely used specification for commercial sulforaphane supplements because of its superior stability and manufacturing practicality.

Typical commercial specifications include:

• <0.5% – Mature broccoli extract, primarily used for whole-food nutritional products
• 5% – Entry-level standardized formulations
• 10% – Mainstream commercial specification for broccoli seed or sprout extract
• 13% – Premium industry benchmark widely adopted by science-backed brands
• 20% – Practitioner-grade formulations
• 30%+ – Customized high-potency ingredients

Most commercial OEM projects utilize 10–13% standardized glucoraphanin, offering the best balance between efficacy, stability, and production cost.

Standardized Sulforaphane

Although active sulforaphane can be supplied as a standardized ingredient, it is inherently unstable and significantly more difficult to manufacture than glucoraphanin.

Typical commercial specifications include:

• 0.1–0.5% – Naturally generated sulforaphane
• 1% – Standard activated ingredient
• 2%+ – Specialty material requiring advanced stabilization technologies

For this reason, most commercial supplements are formulated with standardized glucoraphanin together with myrosinase rather than pre-activated sulforaphane, providing better shelf stability while allowing sulforaphane to be generated after consumption.

Myrosinase Activity

Myrosinase is the enzyme responsible for converting glucoraphanin into biologically active sulforaphane. Without sufficient enzyme activity, the conversion efficiency may be significantly reduced.

Typical commercial activity levels include:

• 1,000–5,000 U/g – Entry-level synergistic formulations
• 10,000–30,000 U/g – Mainstream commercial formulations
• 50,000+ U/g – High-activity premium formulations requiring specialized stabilization

Depending on formulation strategy, myrosinase may be supplied as a purified enzyme or naturally retained through carefully processed broccoli sprout powder.

Recommended Specifications by Product Positioning

KS Nutripharma Selection Principles

When developing commercial sulforaphane supplements, we recommend evaluating raw materials based on total formulation performance rather than specification alone.

✔ Select standardized glucoraphanin instead of relying solely on extract ratios.

✔ Evaluate the effective glucoraphanin delivered per serving, not just the percentage specification.

✔ Choose the appropriate raw material source (seed, sprout, or mature broccoli) according to your product positioning.

✔ Consider myrosinase activity, stability, and manufacturing feasibility together when selecting formulation strategies.

✔ Request HPLC-verified specifications, stability data, and complete batch traceability before commercialization.

Specification Does Not Equal Daily Intake

A higher specification does not automatically result in a more effective product. The actual amount of glucoraphanin delivered per serving is often more important than the percentage listed in the raw material specifications.

For most commercial formulations, a daily intake of 15–30 mg of standardized glucoraphanin provides a practical balance between efficacy, formulation flexibility, and production cost.

Sulforaphane products can be affected by active form, moisture, processing exposure, enzyme activity, powder characteristics and packaging. These factors are reviewed during formulation development so that potential issues can be identified before commercial production.

Active Stability

Free sulforaphane is sensitive to heat, moisture and oxidation. Development therefore reviews processing exposure, excipient selection, raw-material specifications and packaging requirements. Glucoraphanin (GR) is generally more stable during processing, but GR-based formulas require separate consideration of the myrosinase system when conversion to sulforaphane is part of the product concept. (Sulforaphane vs Glucoraphanin)

Moisture Control

Moisture control is particularly important for hygroscopic extracts and enzyme-containing systems. For capsule production, the manufacturing specification identifies ≤45% RH during encapsulation as a controlled condition. Finished-product packaging is selected according to moisture sensitivity, container barrier properties, headspace and desiccant requirements.

GR + Myrosinase Activity

When myrosinase is included, enzyme activity becomes a defined quality parameter rather than an assumed characteristic of the formula. Activity can be evaluated using a spectrophotometric sinigrin-hydrolysis method at incoming raw-material, in-process and finished-product stages where required by the approved specification.

Powder Flow & Fill Performance

Broccoli sprout extracts and other Sulforaphane raw materials can vary substantially in particle size, bulk density and flowability. A preliminary bulk-density range of approximately 0.3–0.6 g/mL may be used for planning, but actual fill weight is confirmed from measured bulk / tapped density and filling trials. Powder-flow characteristics can be evaluated with reference to USP <1174> where applicable.

Multi-Ingredient Compatibility

Vitamins, minerals and botanical extracts can change moisture behavior, flowability, blend uniformity or capsule capacity. Compatibility is therefore reviewed before commercial production. If ingredients have materially different stability requirements, physical separation or a different delivery configuration may be more appropriate than forcing all components into one blend.

Packaging & Stability

Packaging is selected together with the formulation rather than after the formula has been finalized. Depending on the product, stability programs may include accelerated testing at 40°C / 75% RH, real-time monitoring, active-assay retention, myrosinase activity, moisture and physical characteristics.

The exact control limits and testing plan are defined by the approved raw-material specification, finished-product specification, target market and commercial packaging configuration.

What This Means For You?

A Sulforaphane formula should not be approved simply because the nominal active dose fits inside a capsule. Active stability, enzyme activity, powder behavior, fill weight, ingredient compatibility and packaging protection need to work together. These checks are intended to identify technical issues before the project moves into full commercial production.

Have an existing formula or target dose?
Send us the active specification, target dosage, capsule format and supporting ingredients for an initial feasibility review.

Request a Sulforaphane Formula Feasibility Review →

Sulforaphane supplements may use glucoraphanin (GR), sulforaphane itself, or a GR + myrosinase system. These approaches are not technically interchangeable because the active form, conversion mechanism and formulation requirements are different.

1. Glucoraphanin (GR)

Glucoraphanin is the precursor used in many broccoli-based Sulforaphane products. GR itself is relatively stable compared with free sulforaphane, which can make it practical for certain finished-product formats.

Development consideration:
The product specification should define GR content and whether a myrosinase source is included or expected to provide conversion.

↓

2. Myrosinase

Myrosinase is the enzyme responsible for converting glucoraphanin into sulforaphane.

Development considerations:
When myrosinase is included in the formulation, enzyme activity becomes an additional quality parameter. Processing conditions, moisture exposure and ingredient compatibility may therefore affect the finished product.

↓

3. Sulforaphane (SFN)

Sulforaphane is the isothiocyanate generated through the enzymatic conversion of glucoraphanin.

Development consideration:
Formulas using free sulforaphane require greater attention to processing and storage conditions because SFN is more reactive than its GR precursor.

What This Means for Product Development

The appropriate system depends on the target active, dosage, raw-material specification, delivery format, stability requirements and product concept.

Glucoraphanin (GR) is the precursor used in many commercial Sulforaphane formulations, while sulforaphane (SFN) is the isothiocyanate generated through enzymatic conversion. The two ingredients have different stability and formulation characteristics.

Related guide: Sulforaphane vs. Glucoraphanin →

KS Nutripharma operates a dedicated sulforaphane production platform — not a general-purpose line adapted for the ingredient. Every step below is optimized specifically for the stability requirements of glucoraphanin, myrosinase, and sulforaphane:

End-to-End Process Flow

Each process step includes defined Critical Process Parameters (CPPs) and in-process control points. Full process validation documentation is available for regulatory submissions and third-party audits.

Manufacturing Capability

Procurement decisions require hard numbers. Here is exactly what KSNutripharma can deliver for your sulforaphane product line:

KS Nutripharma applies Quality by Design principles to every sulforaphane project. We define Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) at project initiation, ensuring quality is engineered into the product — not tested in at the end.

Critical Quality Attributes (CQAs)

Critical Process Parameters (CPPs)

Risk Assessment & Risk Control

Every sulforaphane manufacturing project at KSNutripharma begins with a formal risk assessment. We identify potential failure modes, evaluate their impact on product quality and patient safety, and implement controls before manufacturing begins.

This risk-based approach is not a one-time exercise. Risk assessments are reviewed and updated at every product revision, complaint investigation, and annual product quality review (APQR).

Standard Batch Documentation

• Certificate of Analysis (COA)— Batch-specific test results for all specification parameters
• Product Specification— Complete quality specification with test methods and acceptance criteria
• Technical Data Sheet (TDS)— Product description, composition, physicochemical properties, handling guidelines
• Material Safety Data Sheet (MSDS)— Safety information, hazard classification, handling precautions, first aid
• Residual Solvent Report— GC-MS analysis confirming compliance with ICH Q3C limits
• Heavy Metal Report— ICP-MS data for Pb, Cd, As, Hg
• Microbiology Report— TAMC, TYMC, specified organism testing per USP <61>, <62>
• Stability Summary— Available stability data with storage conditions and retest period

Regulatory & Compliance Statements

• Allergen Statement— Free from major allergens; customizable per market requirements
• Non-GMO Statement— Available for non-GMO formulations
• BSE/TSE Statement— Free from bovine spongiform encephalopathy / transmissible spongiform encephalopathy risk materials
• Halal Certificate— Available upon request
• Kosher Certificate— Available upon request
• ISO 22000— Certified
• FSSC 22000— Certified
• cGMP Compliance— Per 21 CFR Part 111 (US) and applicable EU regulations

We provide end-to-end packaging services from primary container selection through finished goods kitting and shipment to your designated warehouse or 3PL.

Primary Packaging

• Amber glass bottles (30cc-240cc) with child-resistant caps — ideal for liquid and softgel products
• PET/HDPE bottles with induction seals — cost-effective for capsules and tablets
• Blister packs (PVC/PVDC, aluminum-aluminum) — retail and travel-friendly formats
• Stand-up pouches and single-serve sachets — powder and stick pack products
• Glass dropper bottles (30mL-120mL) — liquid formulations and functional shots

Label & Design Services

• In-house design team with supplement industry expertise
• Regulatory-compliant label review for structure/function claims
• Multi-language label capabilities (English, Spanish, French, German)
• Amazon FBA-compliant labeling and bundling

Secondary Packaging

• Retail cartons with UPC barcodes
• Display-ready case packaging
• Subscription box format optimization

We structure minimum order quantities to support brands at every stage of growth, from market testing to national retail distribution.

Samples & Prototyping

• Pre-formulated samples: Free (shipping cost applies); 5-7 business days
• Custom formula prototype: $500-2,000; 2-3 weeks
• Pilot batch (minimum 100 units): Available for validation testing

Pricing Structure

Unit pricing is determined by order volume, dosage form complexity, and formula customization level. Pre-formulated products offer the most competitive pricing. Custom formulations include a one-time development fee of $500-2,000 depending on complexity and number of prototype iterations required.

Scaling Notes

Lead times assume formula finalization and packaging artwork approval. First-time custom formulations add 2-4 weeks for development and stability screening. Rush production may be available for established formulas — contact your project manager for scheduling.